Tamer I Khayal is Chief Commercial Officer of TransMedics Group, Inc.. Currently has a direct ownership of 20,843 shares of TMDX, which is worth approximately $1.58 Million. The most recent transaction as insider was on Apr 21, 2023, when has been sold 12,026 shares (Common Stock) at a price of $16.14 per share, resulting in proceeds of $194,099. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20.8K
0% 3M change
44.99% 12M change
Total Value Held $1.58 Million

Tamer I Khayal Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 21 2023
BUY
Exercise of conversion of derivative security
$194,099 $16.14 p/Share
12,026 Added 31.3%
26,401 Common Stock
Feb 28 2023
SELL
Open market or private sale
$801,500 $80.15 p/Share
10,000 Reduced 41.03%
14,375 Common Stock
Feb 28 2023
BUY
Exercise of conversion of derivative security
$161,400 $16.14 p/Share
10,000 Added 29.09%
24,375 Common Stock
Feb 23 2023
SELL
Open market or private sale
$2,617,141 $72.84 p/Share
35,930 Reduced 71.42%
14,375 Common Stock
Feb 23 2023
BUY
Exercise of conversion of derivative security
$577,395 $16.07 p/Share
35,930 Added 41.67%
50,305 Common Stock
Feb 20 2023
BUY
Grant, award, or other acquisition
-
13,075 Added 47.63%
14,375 Common Stock
Feb 14 2023
SELL
Open market or private sale
$285,510 $70.15 p/Share
4,070 Reduced 75.79%
1,300 Common Stock
Feb 14 2023
BUY
Exercise of conversion of derivative security
$65,120 $16.0 p/Share
4,070 Added 43.11%
5,370 Common Stock
Jan 23 2023
SELL
Open market or private sale
$204,449 $65.07 p/Share
3,142 Reduced 70.73%
1,300 Common Stock
Jan 23 2023
BUY
Exercise of conversion of derivative security
$50,272 $16.0 p/Share
3,142 Added 41.43%
4,442 Common Stock
Jan 20 2023
SELL
Open market or private sale
$362,437 $65.21 p/Share
5,558 Reduced 81.04%
1,300 Common Stock
Jan 20 2023
BUY
Exercise of conversion of derivative security
$88,928 $16.0 p/Share
5,558 Added 44.76%
6,858 Common Stock
Jan 18 2023
SELL
Open market or private sale
$84,643 $65.11 p/Share
1,300 Reduced 50.0%
1,300 Common Stock
Jan 18 2023
BUY
Exercise of conversion of derivative security
$20,800 $16.0 p/Share
1,300 Added 33.33%
2,600 Common Stock
Jan 13 2023
SELL
Open market or private sale
$355,180 $60.2 p/Share
5,900 Reduced 81.94%
1,300 Common Stock
Jan 13 2023
BUY
Exercise of conversion of derivative security
$94,400 $16.0 p/Share
5,900 Added 45.04%
7,200 Common Stock
Jan 03 2023
SELL
Open market or private sale
$253,790 $61.9 p/Share
4,100 Reduced 75.93%
1,300 Common Stock
Jan 03 2023
BUY
Exercise of conversion of derivative security
$65,600 $16.0 p/Share
4,100 Added 43.16%
5,400 Common Stock
Nov 15 2022
SELL
Open market or private sale
$255,495 $60.06 p/Share
4,254 Reduced 76.59%
1,300 Common Stock
Nov 15 2022
BUY
Exercise of conversion of derivative security
$9,401 $2.21 p/Share
4,254 Added 43.37%
5,554 Common Stock
Nov 11 2022
SELL
Open market or private sale
$162,201 $60.03 p/Share
2,702 Reduced 67.52%
1,300 Common Stock
Nov 11 2022
BUY
Exercise of conversion of derivative security
$5,971 $2.21 p/Share
2,702 Added 40.3%
4,002 Common Stock
Nov 07 2022
SELL
Open market or private sale
$182,761 $60.04 p/Share
3,044 Reduced 70.07%
1,300 Common Stock
Nov 07 2022
BUY
Exercise of conversion of derivative security
$6,727 $2.21 p/Share
3,044 Added 41.2%
4,344 Common Stock
Aug 24 2022
SELL
Open market or private sale
$99,235 $50.22 p/Share
1,976 Reduced 60.32%
1,300 Common Stock
TIK

Tamer I Khayal

Chief Commercial Officer
Andover, MA

Track Institutional and Insider Activities on TMDX

Follow TransMedics Group, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TMDX shares.

Notify only if

Insider Trading

Get notified when an Trans Medics Group, Inc. insider buys or sells TMDX shares.

Notify only if

News

Receive news related to TransMedics Group, Inc.

Track Activities on TMDX